Predictors of outcomes in myasthenia gravis
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study looks at what helps predict outcomes in people with myasthenia gravis (MG). It may help doctors better forecast how MG will progress and which factors matter most for recovery and long-term health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 16 or older.
- Have a confirmed diagnosis of myasthenia gravis (MG).
- Your MG diagnosis must be supported by one of these: a clear improvement after pyridostigmine, or nerve testing that shows a drop of more than 10%.
- Be willing to have extra tests, including sample collection (like blood or other samples) and imaging scans.
- You should not have another long-term brain or nervous system condition (or severe psychiatric illness) that could also cause weakness or tiredness.
- You should not have a very serious whole-body illness that is expected to limit life expectancy soon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable sensors and smartphone apps to track your myasthenia gravis symptoms over time. It aims to see how well these technologies can measure your condition in daily life, which could help you and your doctor manage your care better.
This trial tests multiple treatment combinations for people with myasthenia gravis (MG), a condition that causes muscle weakness. It aims to find safer and more effective options by comparing different therapies.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.
This 10-year study collects information from people with myasthenia gravis to learn more about the condition and improve care. By sharing your experiences, you can help researchers understand what daily life is like and shape future treatments.
This study examines how the thymus gland and specific antibodies relate to myasthenia gravis, a condition causing muscle weakness. Researchers will compare people with different thymus problems and antibody patterns to better understand the disease.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.